
AccuGenomics Seeks to Standardize Gene Expression Tests for Early Leukemia and Lung Cancer Detection
AccuGenomics is currently recruiting lung cancer patients for clinical trials of their Lung Cancer Risk Test
AccuGenomics is currently recruiting lung cancer patients for clinical trials of their Lung Cancer Risk Test
Research indicates that the financial crisis has led to a shift in the popularity, focus, and types of deals that are being done.
Congestive heart failure affects as many as 5 million Americans and with an aging population, more than half a million patients are diagnosed with the condition each year.
CorInnova is currently trialing a cardiac compression device known as CorAmend that can be implanted and explanted without ever contacting the patient’s blood
The Cyclone System allows a surgeon to eliminate the aortic side-biting clamp traditionally used in coronary artery bypass grafting (CABG).
The internet has ushered in a new era in Medical Devices as they begin to provide connectivity and communications to the health system to monitor the patient and provide critical clinical information.
Thermalin’s therapeutic proteins will address medical needs related to diabetes and its complications.
The company’s lead drug candidate for Alzheimer’s Disease (AD), ANAVEX 2-73, has successfully completed a Phase 1 single ascending dose clinical trial.
India is emerging as a significant player in the life science sector. The 2005 patent amendments have brought India into the modern world in terms of intellectual property.
Nearly 40 percent of oral cancer patients will die within five years of diagnosis.
Copyright © 2025 | WordPress Theme by MH Themes